Kaja, a dedicated MPharm professional (PharmD/US) with a solid background in genomics and entrepreneurship, is passionate about advancing healthcare through innovative approaches. Specializing in genomic medicine, rare genetic disorders, and AI in healthcare, she focuses on early diagnosis of pre-symptomatic and early-symptomatic rare disease patients.
Committed to increasing diagnostic rates and reducing the burden of diseases, Kaja leverages a digital approach, genetic screening, newborn screening, consortia-based initiatives, and partnerships. Her collaborative spirit extends to working with key opinion leaders, medical experts, ventures, incubators, start-ups, and more.
With a growth-oriented and creative mindset, Kaja is a connector, original thinker, and results-driven professional. As an enthusiastic and collaborative leader, she navigates the intersection of healthcare and technology to make a meaningful impact.
For many patients, the path to an accurate diagnosis is long, complex, and often life-altering. This panel will explore how timely and precise diagnosis can influence patient well-being, access to care, and long-term outcomes. By bringing together perspectives from clinicians, patient advocates, and healthcare experts, we will discuss opportunities to shorten diagnostic journeys, reduce uncertainty, and ensure that the process itself supports true patient centricity.